acetogenins

https://clinicaltrials.gov/ct2/show/NCT04141969

A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome (PLDS)

Detailed Description:
A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome will be evaluated during a double blind, placebo controlled study. This study is an expansion of RLP042019 NCT04078841 Treating Post-Lyme Disease Syndrome With Acetogenins

Study Design
Go to sections
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
Official Title: A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome
Actual Study Start Date : November 29, 2019
Estimated Primary Completion Date : April 14, 2020
Estimated Study Completion Date : April 28, 2020

https://clinicaltrials.gov/ct2/show/NCT04078841

Treating Post-Lyme Disease Syndrome With Acetogenins

Detailed Description:
To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS). After failure of antibiotic therapy to relive persistent symptoms of Lyme Disease, the use of Acetogenins to elevate Post-Lyme Disease Syndrome.

Study Design
Go to sections
Study Type : Interventional
Actual Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
Official Title: Using ReaLife+ to Treat Post-Lyme Disease Syndrome
Actual Study Start Date : July 1, 2019
Actual Primary Completion Date : November 14, 2019
Estimated Study Completion Date : January 30, 2020